• Accueil >
  • Publications >
  • Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer

Pre-treatment [18F]FDG PET/CT biomarkers for the prediction of antibody–drug conjugates efficacy in metastatic breast cancer

1 janv. 2025European Journal of Nuclear Medicine and Molecular Imaging

DOI : 10.1007/s00259-024-06929-x

Auteurs

Romain-David Seban, Laurence Champion, Alexandre De Moura, Florence Lerebours, Delphine Loirat, Jean-Yves Pierga, Lounes Djerroudi, Thomas Genevee, Virginie Huchet, Nina Jehanno, Francois-Clement Bidard, Irene Buvat

Membres

IRENE BUVAT

Directeur de recherche CNRS